WellDoc

By Jonah Comstock June 13, 2016
A number of pieces of interesting health tech news came out of the 76th Annual Scientific Sessions of the American Diabetes Association, held this weekend in New Orleans. Here’s a roundup of the highlights. Updated 6/15/2016 to include some more news items. IBM’s Medtronic partnership gets a name. Information has been trickling out about Medtronic’s collaboration with IBM Watson Health that was...
By Aditi Pai March 1, 2016
Baltimore, Maryland-based WellDoc has announced a collaboration with LifeScan, a Johnson and Johnson company that makes blood glucose meters. WellDoc also raised an additional $7.5 million from Johnson & Johnson Innovation and other investors, bringing the company’s total funding in its most recent round to $29.5 million.  Existing investors include Samsung Ventures, Merck Global Health...
By Aditi Pai December 17, 2015
Baltimore, Maryland-based WellDoc has raised $22 million in a round led by Samsung Ventures and Merck Global Health Innovation (GHI) Fund with participation from Adage Capital Management, Excel Venture Management, Alexandria Venture Investments and Hudson River Capital Partners. The company will use the funds to focus on growing adoption of its flagship offering, BlueStar, an FDA-cleared mobile...
By Brian Dolan September 22, 2015
Mobile health company WellDoc's former chief strategy and commercial officer Chris Bergstrom has joined the Boston Consulting Group (BCG) as an associate director in the company's healthcare practice. Bergstrom left WellDoc, where he remains an investor, at the beginning of 2015 but served as an advisor for some months afterward. As a member of WellDoc's founding team, Bergstrom was instrumental...
By Jonah Comstock August 19, 2015
WellDoc and Samsung will bring a new version of WellDoc's BlueStar mobile prescription therapy for diabetes to 300 Toronto citizens in partnership with the Ontario Telemedicine Network (OTN), a Canadian government-funded nonprofit. The new offering, BlueStar-S, will combine features of BlueStar and Samsung S Health. "Think of Samsung as a critical boost to what BlueStar already delivers," Anand...
By Aditi Pai May 4, 2015
Ford's 2011 visualization of heart rate monitoring seats Ford has confirmed that it will no longer continue a multiyear research initiative to embed heart rate sensors in its car seats, according to a report from the Financial Times. The carmaker explained that one reason they decided to halt the initiative on heart rate-sensing seats is that there are cheaper and more precise heart rate ...
By Brian Dolan March 24, 2015
Chris Bergstrom Recent months have brought with them a number of important hires and departures at digital health companies. Here's a roundup of some of the ones we've been tracking. Feel free to add your own in the comments below. Chris Bergstrom has stepped away from his full-time position of Chief Strategy and Commercial Officer at WellDoc, but he will remain an advisor to the company. As a...
By Brian Dolan January 28, 2015
This week the Federal Trade Commission published a report focused on privacy and security issues related to the massive Internet of Things (IoT) trend, which includes the growing number of connected health devices. The report summarizes the discussions that took place at an FTC-hosted workshop in November 2013, and it also includes recommendations for the industry from FTC's staff, which they put...
By Aditi Pai August 14, 2014
By the end of the second quarter this year, digital health funding had already surpassed the total funding for 2014, according to a June 2014 report from Rock Health. This growth also shows in the top funded companies for the first half of the year. While Proteus Digital Health received the largest investment in the first half of 2014 as well as the first half of 2013, last year Proteus raised $...
By Brian Dolan July 8, 2014
During a fireside chat at the annual Khosla Ventures CEO summit, investor Vinod Khosla talked to Google co-founders Larry Page and Sergey Brin about Google becoming a health company one day. As David Shaywitz wrote in a column for Forbes, Page and Brin see their company's health initiatives as "cool" projects, but they argue because of all the red tape in healthcare they are ultimately not...

Editor's Pick